Abstract
This document proposes an array of recommendations for a National Plan of Action to accelerate the discovery and development of therapies to delay or prevent the onset of disabling symptoms of Alzheimer's disease. A number of key scientific and public-policy needs identified in this document will be incorporated by the Alzheimer Study Group into a broader National Alzheimer's Strategic Plan, which will be presented to the 111th Congress and the Obama administration in March 2009. The Alzheimer's Strategic Plan is expected to include additional recommendations for governance, family support, healthcare, and delivery of social services.
Publication types
-
Consensus Development Conference
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Academies and Institutes
-
Aged
-
Alzheimer Disease / diagnosis
-
Alzheimer Disease / physiopathology*
-
Alzheimer Disease / therapy*
-
Clinical Trials as Topic / economics
-
Clinical Trials as Topic / legislation & jurisprudence
-
Clinical Trials as Topic / standards*
-
Drug Design
-
Drug Industry / economics
-
Drug Industry / legislation & jurisprudence
-
Drug Industry / standards
-
Federal Government
-
Health Policy / economics
-
Health Policy / legislation & jurisprudence*
-
Health Policy / trends
-
Humans
-
Interdisciplinary Communication
-
National Health Programs / economics
-
National Health Programs / legislation & jurisprudence
-
National Health Programs / standards*
-
Outcome Assessment, Health Care
-
Registries / standards
-
Research Design
-
United States